GENERICS.(Barr Laboratories , Ivax Corp. receive approval for flutamide product)(Brief Article)

Chemical Market Reporter, October, 2001

GENERICS companies Barr Laboratories and Ivax Corp. have received FDA approval for 125 mg flutamide capsules, the equivalent of Schering Corp.'s Eulexin. A shareholder vote on Barr's proposed merger with Duramed Pharmaceuticals is expected by late October.

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement